As 2024 draws to a close, we’re celebrating a fantastic year of content.
From insightful expert Q&As and peer-reviewed articles to conference highlights and a wealth of medical education, it’s been a year filled with content that we hope has been useful to our audience. We’ve had the privilege of connecting with leading experts and working alongside medical societies to support the respiratory and pulmonary medicine community with high-quality, easily accessible content. Here are just a few of our standout moments from the past year.
Most read article:
Camlipixant: A New Treatment Option for Refractory Chronic Cough?
Stephen K Field reviews camlipixant, a potential new treatment option for patients with refractory chronic cough.
Most watched video:
Mirtazapine does not alleviate severe breathlessness: Insights from the BETTER-B study
In this interview, Prof. Irene Higginson discusses the BETTER-B study, which provided new insights into the management of severe breathlessness in patients with chronic respiratory diseases such as COPD and Interstitial Lung Disease (ILD).
Most viewed news story:
GINA 2024: Key Updates to optimise asthma care standards
The Global Initiative for Asthma (GINA) released it’s 2024 update as a comprehensive guie for primary care practitioners, specialists and other healthcare professionals involved in asthma care.
Stay informed in 2025 – sign up for our newsletter and get the latest content delivered directly to your inbox.
